Event:	Central Nervous System Disease Conference
Date/Time:	Thursday, November 17, 2016
Location:	Maxim Group LLC, New York, NY

Related Posts

Anavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Clinical Study in Early Alzheimer’s Disease 
October 9, 2019

Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73 for the Treatment of Alzheimer’s Disease
October 2, 2019

Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference Preliminary Clinical Efficacy Data from the U.S. Rett Syndrome Phase 2 ANAVEX®2-73 Study
September 27, 2019

Anavex Life Sciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference
September 18, 2019